Search Results 1271-1280 of 21442 for anti-TNF drugs

  1. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. ... Subjects with no prior systemic anti cancer ...

  2. Phenothiazine (Oral Route, Parenteral Route, Rectal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Tacrolimus (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Naftifine (Topical Route) Before Using - Mayo Clinic

    Drug Interactions. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an ...

  5. Donepezil (Transdermal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Adlarity. Descriptions. Donepezil skin patch is used to ...

  6. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  7. Zonisamide (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  8. Tuberculin (Intradermal Route) Precautions - Mayo Clinic

    Make sure your doctor knows if you are using a medicine that weakens your immune system, such as a steroid or cancer treatment. Tuberculin skin test should not ...

  9. Pertuzumab, Trastuzumab, And Hyaluronidase-Zzxf (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    It is also used after an initial treatment plan to treat HER2-positive early breast cancer which has a high risk of occurring again.

  10. Tegaserod (Oral Route) Description and Brand Names - Mayo Clinic

    Your doctor will then contact FDA's Division for Drug Information about the emergency IND process at druginfo@fda.hhs.gov. This medicine is available only with ...